Int. J. Environ. Res. Public Health 2006, 3(2), 136-140; doi:10.3390/ijerph2006030017
Article

Dose- and Time-Dependent Response of Human Leukemia (HL-60) Cells to Arsenic Trioxide Treatment

Clement G. Yedjou, Pamela Moore and Paul B. Tchounwou* email
Molecular Toxicology Research Laboratory, NIH-RCMI Center for Environmental Health, College of Science, Engineering and Technology, Jackson State University, 1400 Lynch Street, P.O. Box 18540, Jackson, Mississippi, USA
* Author to whom correspondence should be addressed.
Received: 15 January 2006 / Accepted: 12 April 2006 / Published: 30 June 2006
PDF Full-text Download PDF Full-Text [154 KB, uploaded 16 September 2008 11:01 CEST]
Abstract: The treatment of acute promyelocytic leukemia (APL) has been based on the administration of all-trans retinoic acid plus anthracycline chemotherapy, which is very effective as first line therapy; however 25 to 30% of patients will relapse with their disease becoming refractory to conventional therapy. Recently, studies have shown arsenic trioxide to be effective in the treatment of acute promyelocytic leukemia. In this study, we used the human leukemia (HL-60) cell line as a model to evaluate the cytoxicity of arsenic trioxide based on the MTT assay. Data obtained from this assay indicated that arsenic trioxide significantly reduced the viability of HL-60 cells, showing LD50 values of 14.26 + 0.5μg/mL, 12.54 + 0.3μg/mL, and 6.4 + 0.6μg/mL upon 6, 12, and 24 hours of exposure, respectively; indicating a dose- and time-dependent response relationship. Findings from the present study indicate that arsenic trioxide is highly cytotoxic to human leukemia (HL-60) cells, supporting its use as an effective therapeutic agent in the management of acute promyelocytic leukemia.
Keywords: Arsenic trioxide; HL-60 cells; exposure time; cytotoxicity; MTT assay

Article Statistics

Click here to load and display the download statistics.

Cite This Article

MDPI and ACS Style

Yedjou, C.G.; Moore, P.; Tchounwou, P.B. Dose- and Time-Dependent Response of Human Leukemia (HL-60) Cells to Arsenic Trioxide Treatment. Int. J. Environ. Res. Public Health 2006, 3, 136-140.

AMA Style

Yedjou CG, Moore P, Tchounwou PB. Dose- and Time-Dependent Response of Human Leukemia (HL-60) Cells to Arsenic Trioxide Treatment. International Journal of Environmental Research and Public Health. 2006; 3(2):136-140.

Chicago/Turabian Style

Yedjou, Clement G.; Moore, Pamela; Tchounwou, Paul B. 2006. "Dose- and Time-Dependent Response of Human Leukemia (HL-60) Cells to Arsenic Trioxide Treatment." Int. J. Environ. Res. Public Health 3, no. 2: 136-140.

Int. J. Environ. Res. Public Health EISSN 1660-4601 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert